DE60330780D1 - Sequenzen des t-zellrezeptors cdr3 und nachweisverfahren - Google Patents

Sequenzen des t-zellrezeptors cdr3 und nachweisverfahren

Info

Publication number
DE60330780D1
DE60330780D1 DE60330780T DE60330780T DE60330780D1 DE 60330780 D1 DE60330780 D1 DE 60330780D1 DE 60330780 T DE60330780 T DE 60330780T DE 60330780 T DE60330780 T DE 60330780T DE 60330780 D1 DE60330780 D1 DE 60330780D1
Authority
DE
Germany
Prior art keywords
sequences
detection method
cell receptor
disclosed
receptor cdr3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330780T
Other languages
English (en)
Inventor
Jingwu Z Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Opexa Pharmaceuticals Inc
Original Assignee
Baylor College of Medicine
Opexa Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine, Opexa Pharmaceuticals Inc filed Critical Baylor College of Medicine
Application granted granted Critical
Publication of DE60330780D1 publication Critical patent/DE60330780D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
DE60330780T 2002-06-05 2003-06-05 Sequenzen des t-zellrezeptors cdr3 und nachweisverfahren Expired - Lifetime DE60330780D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38628702P 2002-06-05 2002-06-05
PCT/US2003/017873 WO2003104407A2 (en) 2002-06-05 2003-06-05 T cell receptor cdr3 sequences and methods for detection

Publications (1)

Publication Number Publication Date
DE60330780D1 true DE60330780D1 (de) 2010-02-11

Family

ID=29736145

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330780T Expired - Lifetime DE60330780D1 (de) 2002-06-05 2003-06-05 Sequenzen des t-zellrezeptors cdr3 und nachweisverfahren

Country Status (16)

Country Link
EP (1) EP1530483B1 (de)
JP (3) JP2005528910A (de)
CN (1) CN1674931A (de)
AT (1) ATE453727T1 (de)
AU (1) AU2003237437B2 (de)
BR (1) BR0311578A (de)
CA (1) CA2485874A1 (de)
DE (1) DE60330780D1 (de)
IL (2) IL165194A (de)
MX (1) MXPA04011646A (de)
NO (1) NO20044945L (de)
NZ (1) NZ537403A (de)
PL (1) PL213315B1 (de)
RU (1) RU2004139045A (de)
WO (1) WO2003104407A2 (de)
ZA (1) ZA200409792B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
EP2884961B1 (de) 2012-08-15 2019-03-06 Tris Pharma Inc. Methylphenidat-kautablette mit verlängerter freisetzung
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
CN108070644B (zh) * 2016-11-08 2021-06-29 国家卫生计生委科学技术研究所 一种妊娠高血压的诊断系统
KR20190129926A (ko) * 2017-03-15 2019-11-20 가꼬우호우징 효고 이카다이가쿠 암 면역요법의 신규 바이오마커
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL165071A (en) * 1990-03-30 2008-06-05 Autoimmune Inc A peptide with the ability to stimulate a subset of T cells from multiple sclerosis patients
JP2003504005A (ja) * 1999-02-23 2003-02-04 ベイラー カレッジ オブ メディスィン Ｔ細胞レセプターＶβ−Ｄβ−Ｊβ配列およびその検出法

Also Published As

Publication number Publication date
IL206650A0 (en) 2011-07-31
EP1530483A2 (de) 2005-05-18
CA2485874A1 (en) 2003-12-18
JP2013126420A (ja) 2013-06-27
EP1530483B1 (de) 2009-12-30
BR0311578A (pt) 2007-04-27
IL206650A (en) 2016-10-31
MXPA04011646A (es) 2005-03-07
IL165194A0 (en) 2005-12-18
JP2005528910A (ja) 2005-09-29
NO20044945L (no) 2004-12-28
ATE453727T1 (de) 2010-01-15
RU2004139045A (ru) 2005-09-10
NZ537403A (en) 2009-10-30
AU2003237437A1 (en) 2003-12-22
WO2003104407A2 (en) 2003-12-18
IL165194A (en) 2010-11-30
WO2003104407A3 (en) 2005-03-24
AU2003237437B2 (en) 2010-11-25
PL374723A1 (en) 2005-10-31
JP2010207226A (ja) 2010-09-24
ZA200409792B (en) 2006-07-26
PL213315B1 (pl) 2013-02-28
CN1674931A (zh) 2005-09-28
EP1530483A4 (de) 2006-05-17

Similar Documents

Publication Publication Date Title
IL206650A0 (en) T cell receptor cdr3 peptide for treating an autoimmune disease
CY1107944T1 (el) Χρησεις του μπορρελιοκτονου επιτοπου (-ων) της πρωτεϊνης c εξωτερικης επιφανειας borrelia burgdorferi (ospc) σαν εμβολιο
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
TW200616657A (en) Therapeutic peptides and method
AU2003261942A1 (en) CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
DE69831007D1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
CY1105380T1 (el) Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων
RU2007115411A (ru) Пептиды hsp60 и их apl-производные и фармацевтические композиции
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
HUP0400499A2 (hu) T-sejt-receptor Vbéta-Dbéta-Jbéta-szekvenciája és eljárások detektálására
WO2004039334A3 (en) CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING
DK1523548T3 (da) Polynukleotidsekvenser, som koder for alkaliske alfa-galactosidaser, og fremgangsmåder til anvendelse heraf
IL169256A0 (en) Metalloprotease proteins
NO20052525D0 (no) Spleisevariant av humant hypofyseveksthormon
WO2004113566A3 (en) Disease related protein network
ATE391913T1 (de) Peptidepitope die von krankheitsfördernden cd4+ t lymphocyten erkannt werden
AU2003302440A1 (en) Nucleic acid probes and method for detecting a target nucleic acid sequence comprise two or more cis- located nucleic acid regions
WO2004009633A8 (en) Serotonin receptor
HUP0301111A2 (hu) Potenciálisan immundomináns acetilkolin-receptor oligopeptideket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2004000882A3 (en) Proteins
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same
ES2125202A1 (es) Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias.
WO2004005331A3 (en) Peptides derived from pep133 (g1p3, 6-16)
WO2004003011A3 (en) Nuclear hormone receptor
WO2004026905A3 (en) Transporter/channel proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition